Wordt geladen...
Relapse recovery: The forgotten variable in multiple sclerosis clinical trials
OBJECTIVE: To determine whether basing the decision to initiate immediate vs delayed disease-modifying therapy (DMT) on extent of recovery after initial relapse affects long-term disability accumulation in a multiple sclerosis (MS) evidence-based setting. METHODS: We analyzed the double-blind, place...
Bewaard in:
| Gepubliceerd in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Lippincott Williams & Wilkins
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6943367/ https://ncbi.nlm.nih.gov/pubmed/31848231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000653 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|